You are viewing an expired study

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Rochester, Minnesota 55905

  • Smoking Cessation

Purpose:

To determine if nalmefene is safe and effective in smoking cessation.


Study summary:

Single centered, randomized, placebo-controlled,double-blind, outpatient pilot study to evaluate the efficacy, safety and tolerability of 2 doses of nalmefene on smoking cessation.


Criteria:

Inclusion Criteria: - Smokers in good general health self reporting more than 15 cigarettes per day Exclusion Criteria: -


NCT ID:

NCT00202696


Primary Contact:

Study Director
Philip Jochelson, MD
Somaxon Pharmaceuticals CMO


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota 55905
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.